Exploring prognostic factors for survival in patients with advanced pancreatic cancer undergoing PD-1 inhibitor immunotherapy by Yue Ma, Shiyun Chen, Guanghai Dai

Get full text

A New Chapter in Colorectal Cancer Treatment: Insights from 2024 ASCO Annual Meeting by Miaomiao GOU, Zhikuan WANG, Guanghai DAI

Get full text

Charlson syndrome index predicted survival in pancreatic cancer patients received immunotherapy by Nan Zhang, Nan Zhang, Shiyun Chen, Yue Shi, Zhikuan Wang, Ru Jia, Guanghai Dai, Guanghai Dai

Get full text

Pre-treatment of hyponatremia as a biomarker for poor immune prognosis in advanced or metastatic gastric cancer: A retrospective case analysis by Yuting Pan, Yue Ma, Huafang Guan, Guanghai Dai

Get full text

Neutrophil-to-Lymphocyte Ratio (NLR) Predicts PD-1 Inhibitor Survival in Patients with Metastatic Gastric Cancer by Miaomiao Gou, Tongtong Qu, Zhikuan Wang, Huan Yan, Yanhai Si, Yong Zhang, Guanghai Dai

Get full text

Efficacy and safety of sintilimab plus bevacizumab and CAPOX as first-line treatment for patients with RAS-mutant, microsatellite stable, metastatic colorectal cancer by Yanrong Wang, Ru Jia, Haiyan Si, Yue Ma, Mengjiao Fan, Nan Zhang, Fangfang Liu, Yue Shi, Yushan Jia, Yaoyue Zhang, Quanli Han, Zhikuan Wang, Guanghai Dai

Get full text

miR-196b strictly regulates and reliably predicts the response to cetuximab in colorectal cancer by Shiyun Chen, Zhaoli Tan, Yanli Lin, Fang Pang, Xiaojie Wu, Xiang Li, Yumeng Cui, Weiling Man, Ying Li, Yanghua Li, Lu Han, Miaomiao Gou, Zhikuan Wang, Guanghai Dai, Youliang Wang

Get full text

Single‐cell sequencing analysis reveals cetuximab resistance mechanism and salvage strategy in colorectal cancer by Shiyun Chen, Zhaoli Tan, Xiaojie Wu, Yanli Lin, Xiang Li, Yumeng Cui, Weiling Man, Fang Pang, Yanghua Li, Faliang Shi, Lu Han, Miaomiao Gou, Li Zhou, Zhikuan Wang, Youliang Wang, Guanghai Dai

Get full text